Evidence map›Paper›PMID 41946867›Full record

ArticleScientific reports2026

Tunable colorless and transparent copoly(ester imide)s and nanocomposites derived from an optimized composition.

Young Chul Choi, Yun Sang Shin, Jin-Hae Chang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Young Chul ChoiDepartment of Advanced Materials and Chemical Engineering, Jeonju University, Jeonju, 55069, Korea.
Yun Sang ShinDepartment of Science Education, Jeonju University, Jeonju, 55069, Korea.
Jin-Hae ChangInstitute of Carbon Technology, Jeonju University, Jeonju, 55069, Korea. changjinhae@hanmail.net.

Funding

Ministry of Education, south Korea 2025-RISE-13-JJU
6 · The paper itself

Abstract

A series of colorless and transparent copoly(ester imide)s (Co-CPEIs) were synthesized by reacting diamine p-xylylenediamine (p-XDA) with two types of dianhydrides of various molar contents, namely 2,7-dihydroxynaphthalene bis(trimellitate anhydride) (NATA) and hydroquinone bis(trimellitate anhydride) (HQTA) in N,N'-dimethylacetamide (DMAc). All the Co-CPEI films synthesized by changing the molar ratio of the two dianhydrides from 0 to 1.0, were colorless, transparent, flexible, and tough. The thermomechanical properties and optical transparencies of the Co-CPEI films were investigated according to the molar compositions of the different dianhydrides. Among the synthesized Co-CPEIs, hybrid films were created by dispersing various concentrations of organoclay into Co-CPEI with a p-XDA: NATA: HQTA molar ratio of 1.0:0.50:0.50. These hybrids were synthesized by a solution intercalation method. STN, the organoclay used for hybridization, was obtained through the organo-modification of hectorite. Various amounts of STN (5-40 w%) were incorporated into the matrix Co-CPEI to obtain Co-CPEI hybrid films. The thermomechanical properties, optical transparency, and clay dispersion morphology of the Co-CPEI hybrid films with various STN contents were investigated and compared. A TEM analysis showed that the clay was uniformly dispersed at a nanoscale until the clay content reached 10 wt%; however, when the clay content exceeded 10 wt%, most of the clay agglomerated. The physical properties of the hybrid containing a specific critical clay content exhibited the highest values, and the physical properties deteriorated when the clay content exceed the critical limit.

Identifiers

PMID41946867
PMCPMC13061898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.